Changes in the activities of two peroxisomal enzymes (catalase and thiolase), some parameters related to oxidative situations, such as conjugated dienes, zinc, iron, copper and superoxide dismutase after the administration of two known peroxisome proliferators (clofibrate and acetylsalicylic acid), and two drugs pharmacologically related to the former (probucol and diflunisal) have been studied in male Wistar rats. Administration of the drugs was made by p.o. for 15 days. After the treatment the rats were killed, their livers and brains were taken out, and their blood was collected. Peroxisomes were purified by differential centrifugation followed by ultracentrifugation. Total RNA was also extracted and the acyl CoA oxidase mRNA expression ...
International audiencePeroxisome proliferators (PPs) are a class of rodent nongenotoxic hepatocarcin...
The existence of a relationship between clofibrate-induced peroxisome proliferation and oxidative st...
Studies described here address structure-activity relationships of novel hypolipidemic agents that i...
Changes in the activities of two peroxisomal enzymes (catalase and thiolase), some parameters relate...
AbstractFenofibrate, the hypolipidemic drug and peroxisome proliferator, was given to mice (0.23% w/...
The effect of a high cholesterol diet on rat liver peroxisomal enzymes was investigated. Chow contai...
This thesis illustrates the effects of ciprofibrate and aspirin, which are widely used for their the...
AbstractPeroxisomes contain enzymes catalyzing the β-oxidation of fatty acids, which have been purif...
AbstractFenofibrate, the hypolipidemic drug and peroxisome proliferator, was given to mice (0.23% w/...
Male and female rats were treated with hypolipidemic agents derived from procetofenic acid, namely f...
AbstractMarked proliferation of rat hepatic peroxisomes is observed after treatment with a new poten...
AbstractThe discovery of the colocalization of catalase with H2O2-generating oxidases in peroxisomes...
The main area of interest of this dissertation was to establish the mechanism of action of the hypol...
The mechanism of induction of peroxisome proliferation by xenobiotics was investigated. Firstly, the...
Peroxisomal proliferators induce in rodents hepatic hyperplasia and hypertrophy; the significant inc...
International audiencePeroxisome proliferators (PPs) are a class of rodent nongenotoxic hepatocarcin...
The existence of a relationship between clofibrate-induced peroxisome proliferation and oxidative st...
Studies described here address structure-activity relationships of novel hypolipidemic agents that i...
Changes in the activities of two peroxisomal enzymes (catalase and thiolase), some parameters relate...
AbstractFenofibrate, the hypolipidemic drug and peroxisome proliferator, was given to mice (0.23% w/...
The effect of a high cholesterol diet on rat liver peroxisomal enzymes was investigated. Chow contai...
This thesis illustrates the effects of ciprofibrate and aspirin, which are widely used for their the...
AbstractPeroxisomes contain enzymes catalyzing the β-oxidation of fatty acids, which have been purif...
AbstractFenofibrate, the hypolipidemic drug and peroxisome proliferator, was given to mice (0.23% w/...
Male and female rats were treated with hypolipidemic agents derived from procetofenic acid, namely f...
AbstractMarked proliferation of rat hepatic peroxisomes is observed after treatment with a new poten...
AbstractThe discovery of the colocalization of catalase with H2O2-generating oxidases in peroxisomes...
The main area of interest of this dissertation was to establish the mechanism of action of the hypol...
The mechanism of induction of peroxisome proliferation by xenobiotics was investigated. Firstly, the...
Peroxisomal proliferators induce in rodents hepatic hyperplasia and hypertrophy; the significant inc...
International audiencePeroxisome proliferators (PPs) are a class of rodent nongenotoxic hepatocarcin...
The existence of a relationship between clofibrate-induced peroxisome proliferation and oxidative st...
Studies described here address structure-activity relationships of novel hypolipidemic agents that i...